Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
12.12
Dollar change
+0.42
Percentage change
3.59
%
IndexRUT P/E- EPS (ttm)-0.76 Insider Own59.64% Shs Outstand43.27M Perf Week-8.73%
Market Cap532.19M Forward P/E- EPS next Y-1.47 Insider Trans19.63% Shs Float17.72M Perf Month183.18%
Income-33.38M PEG- EPS next Q-0.25 Inst Own50.65% Short Float1.92% Perf Quarter293.51%
Sales0.00M P/S- EPS this Y45.67% Inst Trans77.99% Short Ratio0.80 Perf Half Y200.74%
Book/sh2.11 P/B5.74 EPS next Y-97.73% ROA-28.17% Short Interest0.34M Perf Year95.48%
Cash/sh2.18 P/C5.57 EPS next 5Y- ROE-31.58% 52W Range2.18 - 13.68 Perf YTD166.37%
Dividend Est.- P/FCF- EPS past 5Y43.00% ROI-34.27% 52W High-11.40% Beta0.95
Dividend TTM- Quick Ratio15.02 Sales past 5Y0.00% Gross Margin- 52W Low455.96% ATR (14)1.08
Dividend Ex-Date- Current Ratio15.02 EPS Y/Y TTM58.51% Oper. Margin0.00% RSI (14)77.21 Volatility8.45% 13.79%
Employees26 Debt/Eq0.06 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price19.21
Option/ShortYes / Yes LT Debt/Eq0.05 EPS Q/Q44.86% Payout- Rel Volume1.24 Prev Close11.70
Sales Surprise- EPS Surprise6.00% Sales Q/Q- EarningsNov 14 BMO Avg Volume422.99K Price12.12
SMA2050.51% SMA50107.39% SMA200192.98% Trades Volume523,000 Change3.59%
Date Action Analyst Rating Change Price Target Change
Nov-17-23Upgrade Citigroup Neutral → Buy $4.50
Oct-19-22Initiated Guggenheim Buy $12
Feb-15-22Downgrade William Blair Outperform → Mkt Perform
Feb-10-21Initiated JMP Securities Mkt Outperform
Feb-01-21Initiated William Blair Outperform $29
Feb-20-24 01:47PM
Feb-19-24 01:48PM
Feb-16-24 04:20PM
Feb-14-24 06:15AM
Feb-13-24 04:18PM
07:00AM Loading…
Feb-12-24 07:00AM
Nov-14-23 07:00AM
Nov-01-23 04:05PM
Oct-03-23 04:05PM
Aug-31-23 04:05PM
Aug-10-23 07:00AM
Aug-07-23 09:22AM
Jul-25-23 09:59AM
07:00AM
Jul-17-23 04:05PM
04:05PM Loading…
Jun-21-23 04:05PM
May-15-23 07:00AM
Mar-28-23 04:05PM
Mar-14-23 07:00AM
Feb-07-23 04:05PM
Nov-21-22 04:05PM
Nov-10-22 07:00AM
Nov-07-22 04:05PM
Oct-20-22 08:00AM
Oct-19-22 04:05PM
Sep-16-22 01:00PM
Sep-14-22 07:04AM
07:01AM
Aug-11-22 04:05PM
Jul-28-22 04:05PM
08:00AM Loading…
Jun-28-22 08:00AM
06:05AM
Jun-02-22 08:00AM
May-19-22 08:00AM
May-12-22 07:00AM
Apr-29-22 06:27AM
Apr-13-22 10:40AM
Mar-25-22 07:00AM
Feb-16-22 11:57AM
Feb-14-22 04:01PM
Jan-19-22 06:53AM
Nov-22-21 07:00AM
Nov-20-21 08:40AM
Nov-15-21 07:00AM
Nov-12-21 07:00AM
Sep-16-21 08:00AM
Sep-02-21 04:01PM
Aug-22-21 10:12AM
Aug-19-21 07:00AM
Aug-12-21 07:00AM
Aug-09-21 08:48AM
Jul-23-21 12:00PM
Jul-08-21 04:01PM
Jun-11-21 07:00AM
Jun-05-21 07:55PM
Jun-02-21 10:56PM
Jun-01-21 04:55AM
May-29-21 10:59PM
May-25-21 05:41PM
May-21-21 09:18AM
May-20-21 04:31PM
May-11-21 07:00AM
May-10-21 04:05PM
Mar-04-21 07:00AM
Mar-01-21 03:54AM
Feb-18-21 04:01PM
Dec-16-20 07:23PM
Dec-15-20 08:00AM
Dec-08-20 07:30AM
Nov-13-20 08:00AM
Nov-10-20 08:00AM
Oct-14-20 10:18PM
Oct-13-20 08:00AM
Sep-21-20 09:58AM
Sep-10-20 08:00AM
Sep-01-20 12:47PM
Aug-11-20 07:00AM
Aug-04-20 08:00AM
Jul-28-20 08:00AM
Jul-20-20 04:15PM
May-29-20 04:05PM
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Flynn James EDirectorFeb 16Buy8.744,290,61737,499,9936,151,406Feb 16 02:37 PM
THOMAS FRANK EDirectorFeb 14Buy11.002,00022,0002,000Feb 15 04:21 PM
Shankar GopiChief Development OfficerDec 07Buy3.735,00018,6625,000Dec 08 04:08 PM
Celano MichaelChief Financial OfficerMay 17Buy3.735,00018,632112,746May 18 02:13 PM
BEN-MAIMON CAROLEPresident and CEOMay 17Buy3.715,00018,525266,829May 18 02:13 PM
Truitt JosephDirectorMay 17Buy3.732,75010,2582,750May 18 02:12 PM